By using our website, you agree to the use of our cookies.


Monthly summary – November 2023

By Karin December 6, 2023

The end of the rate hiking cycle and rallies in both equities and bonds! After three dismal months where investors fretted about rising bond yields, uncertainty over inflation and/or recession, and the geopolitical situation, sentiment positioning was at a year low at the end of October. In November, however, all these concerns seemed to dissipate […]

Monthly summary – October

By Karin November 7, 2023

Rising bond yields, recession fears and war! Following a dismal performance in August and September, equity markets continued down in October with a third consecutive month of falling prices. On top of the worries of “higher for longer” bond yields and the implicit risk for the overall economy going forward, the Hamas terrorist attack against […]

The complex reality of investing in Biopharma

By Karin October 12, 2023

There has been a lot of buzz recently about the new treatment methods for Alzheimer’s disease and obesity. These breakthroughs are encouraging for patients and their families and bring hope of a better quality of life. Beneath the surface of these positive readouts, we see an ever-growing number of clinical trials in various therapeutic areas […]

Monthly summary – September

By Karin October 4, 2023

Rising rates and recession fears. The seasonal pattern of a weak late summer and early autumn came true once again, and equity markets sold off in September. In the absence of earnings reports and other major corporate news, investors focused solely on macroeconomic developments, especially in the US. Interest was centered on several issues: Fast […]


By Karin September 6, 2023

Summer doldrums! Following a five-month stretch of rising global stock prices, equity markets fell back slightly in August. After a better-than-feared earnings report season, investors re-focused on macro events. The tug-of-war in opinion regarding future central banks rate hikes, significantly higher yields on long-term government bonds, as well as worries over developments in the Chinese […]

Monthly summary – June 2023

By Karin July 6, 2023

Rates, recession and a Russian uprising! After the dominating themes in May; the US debt ceiling on one hand and the brilliant prospects of Artificial Intelligence on the other, evaporated from investor’s minds and central banks’ policies and the risk of a looming recession took center stage in June. Following a fantastic first half of […]

Susanna Urdmark to leave Rhenman & Partners

By Camilla June 16, 2023

Susanna Urdmark, Co-head and senior fund manager, has decided to leave the firm after six years to pursue other opportunities. Susanna will leave her position during summer. “I would like to thank Susanna for her important contribution to the fund’s successful development, and wish her all the best on the journey ahead”, says Henrik Rhenman, […]

Monthly summary – April 2023

By Karin May 5, 2023

Strong earnings beat weak regional banks! Following the collapse of Silicon Valley Bank and Credit Suisse in March, market action was dominated by fears of a full-blown bank crisis not seen since 2008. As these fears successively subsided, even though problems remained for some regional banks such as First Republic, investors in April choose to […]

Monthly summary – March 2023

By Karin April 6, 2023

During the latter part of 2022 and in the first two months of this year, bank shares performed strongly on the perception that higher interest rates generally improve bank earnings. However, that view came to a screeching halt when Silicon Valley Bank went under in a matter of a few days and was taken over […]

Visa fler nyheter